Head and Neck Cancer

Featured

Quiz
True or False: In combination with radiotherapy, cisplatin is inferior to cetuximab for the locoregional control of advanced head and neck squamous cell cancer.
News
Machine learning models achieve clinically acceptable accuracy in image segmentation tasks in radiotherapy planning and…
News
The FDA granted approval to pralsetinib for patients with advanced or metastatic RET-mutant medullary thyroid cancer or…
News
In combination with radiotherapy, cetuximab is inferior to cisplatin for the locoregional control of advanced head and…
News
Findings from a recent analysis show the collection of electronic PROs during radiotherapy is feasible for patients…